000			02034 a2200553 4500
005			20250517034543.0
264		0	_c20170116
008			201701s 0 0 eng d
022			_a1434-9949
024	7		_a10.1007/s10067-015-2988-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aChopra, Arvind
245	0	0	_aItolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study. _h[electronic resource]
260			_bClinical rheumatology _cApr 2016
300			_a1059-64 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntirheumatic Agents _xadministration & dosage
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Therapy, Combination _xmethods
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndia
650	0	4	_aMale
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aPatient Safety
650	0	4	_aReproducibility of Results
650	0	4	_aRheumatology _xmethods
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTreatment Outcome
700	1		_aChandrashekara, S
700	1		_aIyer, Rajgopalan
700	1		_aRajasekhar, Liza
700	1		_aShetty, Naresh
700	1		_aVeeravalli, Sarathchandra Mouli
700	1		_aGhosh, Alakendu
700	1		_aMerchant, Mrugank
700	1		_aOak, Jyotsna
700	1		_aLondhey, Vikram
700	1		_aBarve, Abhijit
700	1		_aRamakrishnan, M S
700	1		_aMontero, Enrique
773	0		_tClinical rheumatology _gvol. 35 _gno. 4 _gp. 1059-64
856	4	0	_uhttps://doi.org/10.1007/s10067-015-2988-9 _zAvailable from publisher's website
999			_c24958356 _d24958356